Town Hall Ventures is a healthcare-focused venture capital firm founded in 2018 by Andy Slavitt, David Whelan, and Meera Mani. Headquartered in New York, the firm was established with a mission to use technology and innovation to improve healthcare for low-income and underserved communities—while generating strong financial returns. Town Hall Ventures was founded on the belief that equitable access to healthcare can coexist with commercial success, challenging the traditional notion that “impact investing” must sacrifice performance.
Town Hall Ventures invests in technology-enabled healthcare companies addressing critical gaps in access, affordability, and quality of care for vulnerable populations.
Its portfolio spans primary care, chronic disease management, behavioral health, home-based care, and value-based healthcare delivery.
The firm focuses on business models that leverage data, technology, and innovative payment systems such as Medicare Advantage and Medicaid to drive large-scale transformation in U.S. healthcare.
In October 2025, Town Hall Ventures raised $440 million for its fourth fund, bringing its total assets under management to $1.4 billion.
The new fund continues the firm’s strategy of investing in high-impact, tech-enabled healthcare startups improving care for underserved populations. Investors in this latest vehicle include notable figures such as John Doerr, chairman of Kleiner Perkins, who has been a backer of the firm since its inception.
Town Hall’s prior funds have shown top-tier performance, with its first fund generating a 33% net internal rate of return since its July 2018 inception, placing it in the top decile of venture returns.
The firm has invested in 35 companies and incubated seven of its own, demonstrating a blend of traditional venture investing and in-house venture building.
Leadership
Town Hall Ventures is led by General Partners Andy Slavitt, David Whelan, and Meera Mani. Slavitt, former Acting Administrator of the Centers for Medicare & Medicaid Services, is widely recognized for his leadership in turning around healthcare.gov and for his deep understanding of public and private healthcare systems. Whelan brings decades of investment experience in health and technology, while Mani contributes expertise in behavioral health and equity-focused care innovation. The trio combines policy insight, operational experience, and venture acumen to back companies at the intersection of innovation and access.
Investment Strategy
The firm’s strategy is centered on scalable innovation for vulnerable populations. Town Hall Ventures partners with founders building solutions in home-based healthcare, behavioral health, senior care, pharmacy management, and data-driven care delivery. It often leads early to growth-stage rounds and plays an active role in company building, drawing on its network of payers, providers, and public health organizations. The firm also launches new companies internally, such as Habitat Health, which provides home care services for low-income seniors in partnership with Kaiser Permanente.
Notable Investments
Town Hall Ventures’ portfolio includes:
Other investments include:
Ten of the firm’s portfolio companies have surpassed the $1 billion valuation mark.
Notable Exits
Town Hall Ventures’ most notable exits include Signify Health (acquired by CVS for $8 billion) and Landmark Health (acquired by Optum for $3.5 billion).
The firm’s early investment in Cityblock Health continues to grow as one of the most successful healthcare startups in the United States.
Other
Town Hall Ventures stands out for its mission-driven yet financially disciplined approach. With deep connections across healthcare systems and public policy, the firm acts as both investor and catalyst for systemic change.
It is among a small group of U.S. venture firms focused on healthcare equity at scale, with proven returns that rival traditional funds.
Andy Slavitt - Co-Founder and General Partner
David Whelan - General Partner
Meera Mani, MD PhD - General Partner
